Effects of Prior Exposure to Conflicting Health Information on Responses to Subsequent Unrelated Health Messages
2 other identifiers
interventional
6,046
1 country
1
Brief Summary
Many population-level public health strategies-including media campaigns and other behavioral interventions, screening recommendations, and vaccination policies-rely on messaging to promote cancer prevention and control. These strategies do not take place in a vacuum; rather, they occur in the context of a broader public information environment, which is increasingly characterized by conflicting and often controversial health information. Although studies have documented that such information is prevalent, a critical question remains unanswered: does exposure to conflicting health information in people's routine interactions with the broader information environment threaten the success of message-based population-level public health strategies? And, if so, who is most susceptible to the effects of such exposure? This study will provide a rigorous empirical test of these critical answered questions, guided by two specific aims: First, to evaluate whether prior exposure to conflicting health information influences responses to subsequent unrelated and uncontested health messages, a phenomenon that has been described as "carryover effects" (Primary Aim); and second, to identify whether there are individual-level differences in how conflict affects responses to these unrelated and uncontested health messages (Secondary Aim).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2020
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 16, 2020
CompletedFirst Posted
Study publicly available on registry
January 30, 2020
CompletedStudy Start
First participant enrolled
July 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2020
CompletedNovember 10, 2020
November 1, 2020
1 month
January 16, 2020
November 9, 2020
Conditions
Outcome Measures
Primary Outcomes (6)
Negative affective responses
* Participants are asked to indicate how "the ad you just saw made you feel" * 7 affective responses are randomly ordered: interested, frustrated, surprised, annoyed, distressed, optimistic, worried (response options: 1 "very slightly or not at all" to 5 "extremely")
Up to 42 days
Counterarguing
• Participants are asked to indicate the extent to which they agree or disagree with 4 statements (randomly ordered; response options: 1 "strongly disagree" to 5 "strongly agree"): * "I found myself agreeing with the ad" (reverse coded) * "I thought of points that went against what the ad was saying" * "I accepted the ad's claims" (reverse coded) * "While reading the ad, I was skeptical of its claims"
Up to 42 days
Reactance/threat to freedom
• Participants are asked to indicate the extent to which they agree or disagree with the following statement (response options: 1 "strongly disagree" to 5 "strongly agree"): "I felt like the ad was trying to manipulate me"
Up to 42 days
Other negative cognitive responses to ad claims
• Participants are asked to indicate whether "the claims in the ad I just saw are" (randomly ordered; response options: 1 "strongly disagree" to 5 "strongly agree"): exaggerated, flawed, believable (reverse coded), reasonable (reverse coded)
Up to 42 days
Perceived argument strength
• Participants are asked to indicate the extent to which they agree or disagree with 2 statements (randomly ordered; response options: 1 "strongly disagree" to 5 "strongly agree"): * "The ad was convincing" * "The ad gave me a strong reason to \[engage in the behavior specified in the ad\]"
Up to 42 days
Response efficacy
• Participants are asked to respond to two items, presented in random order: * "How confident are you that there is evidence to support the ad's claims?" (1 "not confident at all" to 7 "extremely confident") * "How much do you think your health would benefit if you \[engaged in the behavior specified in the ad\]?" (1 "not at all" to 7 "extremely")
Up to 42 days
Study Arms (2)
No exposure to conflict
PLACEBO COMPARATORExposure to conflict
EXPERIMENTALInterventions
At 2 time points across a \~28-day period, participants will be exposed to news stories and social media posts about 6 health topics: mammography screening, prostate-specific antigen (PSA) testing, Vitamin D supplementation, carbohydrate consumption, alcohol consumption, and breastfeeding. Participants in the conflict (experimental) group will have conflicting information added to these news and social media posts.
At 2 time points across a \~28-day period, participants will be exposed to news stories and social media posts about 6 health topics: mammography screening, prostate-specific antigen (PSA) testing, Vitamin D supplementation, carbohydrate consumption, alcohol consumption, and breastfeeding. Participants in the no conflict (comparator) group will have no conflicting information included in these news and social media posts.
Eligibility Criteria
You may qualify if:
- + U.S. adults
- Members of NORC's AmeriSpeak Panel (https://amerispeak.norc.org/Pages/default.aspx)
- Able to complete web-based survey
- Able to read in English
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Minnesotalead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
NORC at the University of Chicago (online only)
Chicago, Illinois, 60603, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 16, 2020
First Posted
January 30, 2020
Study Start
July 20, 2020
Primary Completion
August 31, 2020
Study Completion
August 31, 2020
Last Updated
November 10, 2020
Record last verified: 2020-11